FDA OKs vitamin C trial for cancer

Jan 12, 2007

Federal approval of a clinical trial on intravenous vitamin C as a cancer treatment lends credence to alternative cancer care, U.S. researchers said.

Cancer Treatment Centers of America said it won Food and Drug Administration approval to begin the trial, a move the Illinois-based hospital group said adds credibility to its research into alternative methods for cancer medical care, the Chicago Tribune said Thursday. It is the first FDA-approved trial for CTCA.

Just a few patients will be eligible, said Christopher Lis, the firm's vice president of research and development.

"Only patients who have exhausted all other conventional treatment options are eligible to receive the therapy," Lis said.

The first phase will be to determine the optimal dose for the patients and to learn whether the treatment is safe and can be tolerated, Lis said. Additional studies over several years would be needed to demonstrate whether it is effective.

Earlier studies conducted with vitamin C supplements administered orally did not to demonstrate a clinical benefit to cancer patients.

Cancer Treatment Centers, with facilities in Illinois, Pennsylvania and Oklahoma, provides traditional and alternative treatment for cancer patients.

Copyright 2007 by United Press International

Explore further: PDE-5 inhibitors tied to prostate cancer biochemical recurrence

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Cancer fear can impact screening uptake

15 hours ago

People who worry about cancer are more likely to want to get screened for colon cancer, but feeling uncomfortable at the thought of cancer makes them less likely to actually go for the test, finds new UCL-led ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.